| Literature DB >> 28509873 |
Audrey R S T Silva1, Ricardo Scher2, Flaviane V Santos3, Sebastião R Ferreira4,5, Sócrates C H Cavalcanti6, Cristiane B Correa7, Lilian L Bueno8, Ricardo J Alves9, Damião P Souza10, Ricardo T Fujiwara11, Silvio S Dolabella12,13.
Abstract
Several constituents of essential oils have been shown to be active against pathogens such as bacteria, fungi, and protozoa. This study demonstrated the in vitro action of ten compounds present in essential oils against Leishmania amazonensis promastigotes. With the exception of p-cymene, all evaluated compounds presented leishmanicidal activity, exhibiting IC50 between 25.4 and 568.1 μg mL-1. Compounds with the best leishmanicidal activity presented a phenolic moiety (IC50 between 25.4 and 82.9 μg mL-1). Alicyclic alcohols ((-)-menthol and isoborneol) and ketones ((-)-carvone) promoted similar activity against the parasite (IC50 between 190.2 and 198.9 μg mL-1). Most of the compounds showed low cytotoxicity in L929 fibroblasts. Analysis of the structure-activity relationship of these compounds showed the importance of the phenolic structure for the biological action against the promastigote forms of the parasite.Entities:
Keywords: Leishmania amazonensis; essential oil; leishmanicidal activity; monoterpenes
Mesh:
Substances:
Year: 2017 PMID: 28509873 PMCID: PMC6154737 DOI: 10.3390/molecules22050815
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
In vitro leishmanicidal activity of different essential oils constituents against Leishmania amazonensis promastigotes.
| Compound | Chemical Structure | IC50 (µg mL−1) * | IC50 (µM) * | R2 |
|---|---|---|---|---|
| Carvacrol (1) | 25.4 ± 2.4 | 169.08 ± 15.97 | 0.70 | |
| Thymol (2) | 26.8 ± 3.7 | 178.40 ± 24.63 | 0.81 | |
| 3-Carene (3) | 72.5 ± 18.5 | 532.18 ± 135.79 | 0.81 | |
| Eugenol (4) | 82.9 ± 6.2 | 504.87 ± 37.75 | 0.98 | |
| Isoborneol (5) | 190.2 ± 9.8 | 1233.06 ± 63.53 | 0.97 | |
| (–)-Carvone (6) | 194.7 ± 16.9 | 1296.09 ± 112.50 | 0.94 | |
| (–)-Menthol (7) | 198.9 ± 12.0 | 1272.87 ± 76.79 | 0.96 | |
| (–)-Linalool (8) | 276.2 ± 24.0 | 1790.59 ±155.59 | 0.91 | |
| 1,8-Cineole (9) | 568.1 ± 56.5 | 3682.98 ± 366.28 | 0.89 | |
| >1000 | >7450.45 | - | ||
| c Amphotericin B | - | 0.05 ± 0.01 | 0.054 ± 0.01 | - |
a IC50 = Drug concentration capable of inhibiting 50% of promastigote multiplication; b R2 = Coefficient of determination—measure for the quality of the curve fitting of sigmoidal dose-response curves; c Amphotericin B was used as positive control. * Represents the mean of three independent experiments conducted in triplicate and expressed with means plus or minus standard deviation (±SD).
Cytotoxic activity of the compounds on L929 fibroblasts.
| Compounds | Viability (%) | |
|---|---|---|
| 50 µg mL−1 | 100 µg mL−1 | |
| 3-Carene | 84.1 ± 6.4 ** | 48.7 ± 6.7 * |
| Carvacrol | 51.3 ± 3.0 | 46.1 ± 2.9 * |
| (−)-Carvone | 65.1 ± 4.7 | 58.2 ± 4.2 |
| 1,8-Cineole | 71.4 ± 0.7 | 66.9 ± 7.8 |
| Eugenol | 78.1 ± 7.0 | 63.1 ± 1.7 |
| Isoborneol | 73.3 ± 9.4 | 72.9 ± 7.5 |
| (−)-Linalool | 65.7 ± 8.2 | 66.7 ± 7.8 |
| (−)-Menthol | 83.8 ± 8.0 ** | 81.2 ± 2.4 ** |
| Thymol | 64.5 ± 4.0 | 58.5 ± 6.7 |
| 91.2 ± 6.6 ** | 87.1 ± 6.7 ** | |
Low cytotoxicity (viability between >50% and <80%); * Moderate cytotoxicity (viability between >30% and <50%); and ** Non-cytotoxic (viability >80%).